Are psychedelic drug treatments seeing a comeback in psychiatry?
Progress in Neurology and Psychiatry October 1, 2008 Benjamin St John Sessa
AbstractAfter a hiatus of nearly 40 years, psychedelic drugs (or hallucinogens) are being increasingly researched as possible adjuncts to psychotherapy for treatment‐resistant anxiety disorders and addictions.This research offers an exciting future for this class of drugs whose image has been tarnished by recreational use since the 1960s.Through cautious and evidence‐based studies, these...